SCA clinches Georgia-Pacific deal

26 July 2012


SCA’s €1.32 billion acquisition of Georgia-Pacific´s European tissue business has been completed. The acquired operations had sales in 2011 amounting to €1.25 billion.

The closing follows the EU clearance and its requirement that SCA divest Georgia-Pacific´s consumer tissue business in the UK including production capacity, Georgia-Pacific´s consumer tissue branded business in Benelux licensing out the Lotus brand during a limited time, and some of Georgia-Pacific´s and SCA´s retailer branded business in Scandinavia, including production capacity. The businesses to be divested account for sales of approximately €200 million.

“The acquisition is a strategic fit that will strengthen our product offering with well-known brands and geographic reach in Europe. It also leads to substantial synergies”, says Jan Johansson, president and CEO of SCA. The annual synergies are estimated at €125 million, with full effect in three years after closing. Related costs are estimated at €130 million.

In a separate transaction, SCA as agreed to sell its packaging division to the UK-based DS Smith Group for €1.7 billion.




External weblinks
Converting Today is not responsible for the content of external internet sites.

SCA



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.